NNC-92041706
- Generic Name
- NNC-92041706
Research Study of a New Medicine (NNC9204-1706) in People With Overweight or Obesity
Phase 1
Completed
- Conditions
- Metabolism and Nutrition DisorderObesity
- Interventions
- Drug: Placebo (NNC9204-1706)
- First Posted Date
- 2018-09-07
- Last Posted Date
- 2019-10-18
- Lead Sponsor
- Novo Nordisk A/S
- Target Recruit Count
- 60
- Registration Number
- NCT03661879
- Locations
- 🇺🇸
Novo Nordisk Investigational Site, Overland Park, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath